Dr. Morgan brings over 25 years of experience in the healthcare and clinical research fields

MORRISVILLE, N.C. (Business Wire) June 10, 2014 – Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the addition of Dr. Roger Morgan, MD, FACS, as Executive Vice President, Global Medical Affairs. Dr. Morgan has extensive experience in global medical affairs with both pharmaceutical companies and CROs. While trained as a surgeon/critical care intensivist, he spent much of his industry career focused on cardiovascular research.

Dr. Morgan provides oversight and leadership for the global Medical Affairs department, including the cardiometabolic team, medical monitoring, and the pharmacovigilance/safety groups. His responsibilities also include providing senior medical/safety oversight of clinical trials to ensure standard operating procedures, sponsor directives, and patient safety regulatory requirements are followed.  In addition, Dr. Morgan will be a resource for the Regulatory and Strategic Development, Business Development, Clinical Operations, and Informatics teams.

“The addition of Roger will make our clinical and medical teams even stronger,” said Jeff Williams, Clinipace CEO. “With his vast therapeutic knowledge and surgical/critical care experience, Roger brings a new perspective to Clinipace as we seek to improve performance and efficiency in clinical trials – particularly within the cardiometabolic area of research.”

Prior to Clinipace, Dr. Morgan served as the Medical Director, then Chief Medical Officer at Kowa Research Institute, where he worked on multiple cardiovascular, endocrine, ophthalmologic, and other therapeutic programs, and evaluated multiple preclinical molecules and potential in-licensing candidates in these areas. He also served as Director of Medical Affairs/Assistant Research Professor for the Department of Surgery at Duke University, and as the Senior Director of Medical/Scientific Services in the Internal Medicine Therapeutics Division at Quintiles.

Dr. Morgan received his M.D. from the University of Illinois College of Medicine and his A.B. in Biochemistry from Duke University. He received General Surgery and Critical Care training at Michigan State University and University of Pittsburgh. He is certified by the American Board of Surgery for Surgical Critical Care and General Surgery, and is a Fellow of the American College of Surgeons.

About Clinipace Worldwide
As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified CRO service model to serve the unique needs of venture-backed, mid-tier, and strategic pharmaceutical, biotechnology, and medical device firms.  Powered by TEMPO™, our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program.  We have managed over 1,800 global clinical research, strategic product development, regulatory, and GxP/CMC/QA projects in therapeutic areas such as cardiovascular & metabolic diseases, central nervous system, dermatology, gastroenterology, immunology, infectious diseases, nephrology, oncology, respiratory, rheumatology, and vaccines (and other cell and tissue based therapies).  Clinipace Worldwide has its global headquarters in Research Triangle Park, NC with additional domestic operations in Irvine, CA, Overland Park, KS, and Boulder, CO; European operations in Zurich, Switzerland, Munich, Germany, and London, United Kingdom; Asian operations in Taipei, Taiwan, China offices in Beijing, Shanghai, Guangzhou, Seoul, South Korea, Hong Kong, Hanoi, Vietnam, Singapore, Kuala Lumpur, Malaysia; South American operations based in Sao Paulo, Brazil, Buenos Aires, Argentina, and Lima, Peru; Middle Eastern operations in Tel-Aviv, Israel and Indian operations in Trivandrum and New Delhi, India.  For more information, visit our website at www.clinipace.com.

Back to News